Literature DB >> 23920375

Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography.

Ermengarda Marziani1, Simone Pomati, Paola Ramolfo, Mario Cigada, Andrea Giani, Claudio Mariani, Giovanni Staurenghi.   

Abstract

PURPOSE: To evaluate differences between the retinal nerve fiber layer (RNFL) thickness and RNFL + ganglion cell layer (GCL) thickness in patients affected by Alzheimer's disease (AD) and healthy patients using spectral-domain optical coherence tomography (SD-OCT).
METHODS: This was a case-control prospective study. Twenty-one AD patients and 21 healthy subjects underwent neurological examination, clock-drawing test (CDT), Mini Mental State Examination (MMSE), and comprehensive ophthalmic evaluation with visual acuity. SD-OCT examination was performed using Spectralis and RTVue-100. An RNFL thickness map was obtained using the Spectralis volume protocol with 19 lines on the 30° field centered on the macula. On each B-scan, the outer RNFL limit was manually set. Statistical analysis was performed to assess interoperator RNFL evaluation thickness. An RNFL+GCL thickness map was obtained using the RTVue-100 MM6 protocol. Maps were divided into the nine ETDRS subfields and each map value in every area was evaluated. A single eye from each patient was randomly chosen to perform the analysis. Differences between AD and healthy subjects were assessed.
RESULTS: The two study groups were age and sex matched. MMSE results were 19.9 ± 3.1 and 27.9 ± 1.3, respectively (P < 0.001). There was good agreement in the manual delimitation of the RNFL layer. There was a significant difference in the thickness of both the RNFL and the RNFL+GCL in all examined fields. For example, in the inferior internal subfield, the RNFL thickness was 28.1 ± 3.1 μm for AD patients and 32.6 ± 3.8 μm for healthy subjects (P < 0.001).
CONCLUSIONS: These results indicate that RNFL and RNFL+GCL thickness measurements are reduced in AD patients compared with healthy subjects. This finding may represent a useful element for the diagnosis and follow-up of this pathology.

Entities:  

Keywords:  Alzheimer's disease; GCL; RNFL; SD-OCT

Mesh:

Year:  2013        PMID: 23920375     DOI: 10.1167/iovs.13-12046

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  80 in total

1.  Inhaled Anesthesia, Apoptosis, and the Developing Retina: A Window into the Brain?

Authors:  Steven Roth
Journal:  Anesth Analg       Date:  2015-11       Impact factor: 5.108

2.  An Association Between Large Optic Nerve Cupping and Cognitive Function.

Authors:  Thasarat Sutabutr Vajaranant; Joelle Hallak; Mark A Espeland; Louis R Pasquale; Barbara E Klein; Stacy M Meuer; Stephen R Rapp; Mary N Haan; Pauline M Maki
Journal:  Am J Ophthalmol       Date:  2019-06-01       Impact factor: 5.258

Review 3.  Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases.

Authors:  Delia Cabrera DeBuc; Gabor Mark Somfai; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

Review 4.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

5.  Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study.

Authors:  Unal Mutlu; Johanna M Colijn; M Arfan Ikram; Pieter W M Bonnemaijer; Silvan Licher; Frank J Wolters; Henning Tiemeier; Peter J Koudstaal; Caroline C W Klaver; M Kamran Ikram
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

Review 6.  OCT: New perspectives in neuro-ophthalmology.

Authors:  Gema Rebolleda; Laura Diez-Alvarez; Alfonso Casado; Carmen Sánchez-Sánchez; Elisabet de Dompablo; Julio J González-López; Francisco J Muñoz-Negrete
Journal:  Saudi J Ophthalmol       Date:  2014-10-05

7.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

8.  Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease.

Authors:  V Polo; M J Rodrigo; E Garcia-Martin; S Otin; J M Larrosa; M I Fuertes; M P Bambo; L E Pablo; M Satue
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

9.  Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Authors:  Nicholas J Volpe; Joseph Simonett; Amani A Fawzi; Teepu Siddique
Journal:  Trans Am Ophthalmol Soc       Date:  2015

10.  Retinal hyperaemia-related blood vessel artifacts are relevant to automated OCT layer segmentation.

Authors:  L J Balk; M Mayer; B M J Uitdehaag; A Petzold
Journal:  J Neurol       Date:  2014-01-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.